BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.1850
-0.0190 (-9.31%)
At close: Mar 3, 2026, 4:00 PM EST
0.1848
-0.0002 (-0.11%)
After-hours: Mar 3, 2026, 7:17 PM EST
BioAtla Market Cap
BioAtla has a market cap or net worth of $13.74 million as of March 3, 2026. Its market cap has decreased by -49.04% in one year.
Market Cap
13.74M
Enterprise Value
11.61M
1-Year Change
-49.04%
Ranking
Category
Stock Price
$0.19
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $13.74M, a decrease of -97.62%. That is a compound annual growth rate of -51.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 13.74M | -59.01% |
| Dec 31, 2025 | 33.51M | -2.30% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -69.81% |
| Dec 30, 2022 | 390.66M | -45.97% |
| Dec 31, 2021 | 723.09M | -36.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pasithea Therapeutics | 20.36M |
| VYNE Therapeutics | 19.99M |
| Polyrizon | 19.91M |
| Cadrenal Therapeutics | 19.85M |
| Serina Therapeutics | 19.41M |
| Intensity Therapeutics | 19.41M |
| Edesa Biotech | 18.37M |
| Jupiter Neurosciences | 18.25M |